ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 617

$325K Total Retail Price of All Prescriptions

Rank: 212 out of 617

215 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 215 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 215 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,301 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 243 229 1 3
LEVOTHYROXINE SODIUM 218 208 2 1
AMLODIPINE BESYLATE 198 198 3 6
FUROSEMIDE 195 195 4 4
HYDROCODONE-ACETAMINOPHEN 179 177 S3 5 8
WARFARIN SODIUM 177 169 6 7
POTASSIUM CHLORIDE 175 175 7 10
SIMVASTATIN 171 171 8 2
SERTRALINE HCL 147 147 9 20
ATORVASTATIN CALCIUM 132 128 10 14
OXYCODONE-ACETAMINOPHEN 120 108 S2 11 93
HYDROCHLOROTHIAZIDE 115 110 12 13
ALBUTEROL SULFATE 111 108 13 112
METFORMIN HCL 104 104 14 9
METOPROLOL TARTRATE 101 101 15 11
FENTANYL 97 97 S2 16 45
CITALOPRAM HBR 96 96 17 18
NAMENDA 95 95 18 35
LANTUS 93 93 19 39
AMLODIPINE BESYLATE-BENAZEPRIL 88 88 20 80
DONEPEZIL HCL 81 81 21 30
LISINOPRIL 69 69 22 5
METOPROLOL SUCCINATE 69 69 22 12
IPRATROPIUM BROMIDE 67 65 24 136
CARVEDILOL 66 66 25 19
PANTOPRAZOLE SODIUM 66 65 25 37
ALLOPURINOL 63 63 27 27
TRICOR 60 50 28 83
BENAZEPRIL HCL 58 58 29 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 29 29
VENLAFAXINE HCL ER 56 44 31 76
MELOXICAM 56 56 31 24
PRAVASTATIN SODIUM 55 55 33 21
LOSARTAN POTASSIUM 52 51 34 22
GABAPENTIN 52 26 34 16
SPIRONOLACTONE 50 50 36 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.